COMMUNIQUÉS West-GlobeNewswire

Iovance Biotherapeutics Announces Clinical Trial Updates with Collaborators MD Anderson and Moffitt Cancer Center
16/08/2018
- First Patient Dosed with LN-145 in Phase 2 Trial with MD Anderson for Treatment of Sarcomas and Ovarian Cancer - - Preliminary Data from Moffitt NSCLC Study to be Presented at the Upcoming 19th World Conference on [...]
Inovio Treats First Patient in Immuno-Oncology Study for Advanced or Metastatic Bladder Cancer in Combination with Roche/Genentech’s Atezolizumab
16/08/2018
One of three ongoing oncology combination studies coupling Inovio’s T cell enhancers with checkpoint inhibitors PLYMOUTH MEETING, Pa., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today [...]
Matinas BioPharma to Present at the U.S. FDA Development of Non-Traditional Therapies for Bacterial Infections Workshop
16/08/2018
BEDMINSTER, N.J., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on enabling targeted intracellular delivery of life-changing [...]
Wave Life Sciences Receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201
16/08/2018
Investigational WVE-210201 in development for treatment of Duchenne muscular dystrophy patients amenable to exon 51 skipping CAMBRIDGE, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a [...]
Lawrence Lamb, Ph.D. Incysus Therapeutics Scientific Co-Founder to Present at 10th Annual Bioprocessing Summit
16/08/2018
NEW YORK, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, announced today [...]
Spring Bank Pharmaceuticals, Inc. Appoints Scott Smith to its Board of Directors
16/08/2018
Former Celgene President & COO Joins Spring Bank Board HOPKINTON, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel [...]
Immutep to Present at the BioCentury 25th Annual NewsMakers in the Biotech Industry Conference
16/08/2018
SYDNEY, Australia, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
NanoVibronix Provides Business Update for the Second Quarter of 2018
16/08/2018
Revenue increases 153% for the second quarter of 2018 ELMSFORD, N.Y., Aug. 16, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low [...]
Arch Therapeutics Announces Poster Presentation at the 2018 Military Health System Research Symposium on Tuesday, August 21, 2018
16/08/2018
Early stage ophthalmology and anti-inflammation pipeline projects highlighted FRAMINGHAM, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) (“Arch” or the “Company”), developer of AC5™ [...]
Resonant Inc. Names Michael Seifert as CFO
16/08/2018
- Seasoned Executive Brings More Than 25 Years Financial Experience - GOLETA, Calif., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Resonant, Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends [...]
Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection
16/08/2018
Brings Total Committed Funding Under BARDA Contract to $44 Million OXFORD, United Kingdom and CAMBRIDGE, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT, AIM:SUMM), a leader in antibiotic [...]
VBL Therapeutics Announces Second Quarter 2018 Financial Results
16/08/2018
Conference Call and Webcast at 8:30am Eastern Time Today VBL is well capitalized, cash sufficient for more than 3 years, beyond key inflection points VBL continues development of VB-111 for Ovarian Cancer with the OVAL [...]
Kamada Announces the End of the Labor Strike in the Company’s Manufacturing Facility; All Employees Returned to Work
16/08/2018
REHOVOT, Israel, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq: KMDA) (KMDA.TA), a plasma-derived protein therapeutics company, today announced that on August 15, 2018, the Company, the Employees’ Committee of [...]
Pain Therapeutics Announces $11.3 Million Registered Direct Offering Priced At-the-Market
16/08/2018
– Proceeds to Be Used for Drug Development, General Corporate Purpose – AUSTIN, Texas, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced that it has [...]
HEXO Celebrates Five Years, 200 Employees … and Growing!
16/08/2018
GATINEAU, Quebec, Aug. 16, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is proud to announce that it has reached two milestones this week. The Company is celebrating its [...]
HEXO célèbre cinq ans et 200 employés... et ça ne fait que commencer!
16/08/2018
GATINEAU, Québec, 16 août 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX:HEXO) est fière d’annoncer qu’elle a franchi deux étapes cette semaine. En effet, la Société célèbre son [...]
Clementia Announces Completion of Enrollment in Phase 3 MOVE Trial for FOP
16/08/2018
Enrollment Completed Four Months Ahead of Schedule; Two Interim Data Analyses On Track for 2019 MONTREAL, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA), a clinical-stage company [...]
Clementia annonce l’achèvement du recrutement de l’essai MOVE, un essai de phase 3 pour la FOP
16/08/2018
Recrutement terminé quatre mois plus tôt que prévu; deux analyses des données intérimaires sont en préparation pour 2019 MONTRÉAL, 16 août 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ : CMTA), une [...]
CEPI Awards Contract Worth up to $36 million to Profectus BioSciences and Emergent BioSolutions to Develop Lassa Virus Vaccine
16/08/2018
OSLO, Norway, BALTIMORE and GAITHERSBURG, Md., Aug. 16, 2018 (GLOBE NEWSWIRE) -- CEPI (the Coalition for Epidemic Preparedness Innovations) today announced a new collaboration with Profectus BioSciences, Inc. and [...]

Pages